A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair—Proficient Colorectal or Pancreatic Cancer
Titel:
A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair—Proficient Colorectal or Pancreatic Cancer
Auteur:
Hernando-Calvo, Alberto Han, Ming Ayodele, Olubukola Wang, Ben X. Bruce, Jeffrey P. Abbas-Aghababazadeh, Farnoosh Vila-Casadesús, Maria Sanz-Garcia, Enrique Yang, S.Y. Cindy Berman, Hal K. Vivancos, Ana Lam, Bernard Lungu, Ilinca Salawu, Abdulazeez Stayner, Lee-Anne Haibe-Kains, Benjamin Bedard, Philippe L. Avery, Lisa Razak, Albiruni R.A. Pugh, Trevor J. Spreafico, Anna Siu, Lillian L. Hansen, Aaron R.